A detailed history of Ubs Asset Management Americas Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 253,770 shares of XBIT stock, worth $1.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
253,770
Previous 248,270 2.22%
Holding current value
$1.68 Million
Previous $1.28 Million 53.68%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.55 - $7.95 $30,525 - $43,725
5,500 Added 2.22%
253,770 $1.96 Million
Q2 2024

Aug 13, 2024

BUY
$4.54 - $9.89 $1.13 Million - $2.46 Million
248,270 New
248,270 $1.28 Million

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $202M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.